Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3
- 26 July 2016
- journal article
- Published by Elsevier BV in Pharmacological Research
- Vol. 111, 804-814
- https://doi.org/10.1016/j.phrs.2016.07.033
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (25861574, 25861573, 24659750, 26293370)
- GSK Japan Research Grant
This publication has 73 references indexed in Scilit:
- Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial CellsPLOS ONE, 2013
- IFN-λsCurrent Opinion in Immunology, 2011
- Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these yearsVirus Research, 2011
- A New Shield for a Cytokine StormCell, 2011
- Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus InfectionCell, 2011
- Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virusProceedings of the National Academy of Sciences of the United States of America, 2011
- Interferon-Lambda: A New Addition to an Old FamilyJournal of Interferon & Cytokine Research, 2010
- Epstein–Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-βVirology, 2010
- Epithelium: At the interface of innate and adaptive immune responsesJournal of Allergy and Clinical Immunology, 2007
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005